Fanconi anemia genes are highly expressed in primitive CD34+hematopoietic cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2052-1839
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Fanconi anemia genes are highly expressed in primitive CD34+hematopoietic cells ; volume:3 ; number:1 ; day:16 ; month:06 ; year:2003 ; pages:1-9 ; date:12.2003
BMC hematology ; 3, Heft 1 (16.06.2003), 1-9, 12.2003
- Urheber
-
Aubé, Michel
- Beteiligte Personen und Organisationen
-
Lafrance, Matthieu
Brodeur, Isabelle
Delisle, Marie-Chantal
Carreau, Madeleine
SpringerLink (Online service)
- DOI
-
10.1186/1471-2326-3-1
- URN
-
urn:nbn:de:1111-2016021828116
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2005, 07:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aubé, Michel
- Lafrance, Matthieu
- Brodeur, Isabelle
- Delisle, Marie-Chantal
- Carreau, Madeleine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tongue cancer following hematopoietic cell transplantation for Fanconi anemia
Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia
Therapeutic gene editing in CD 34 + hematopoietic progenitors from Fanconi anemia patients
Deregulated protein homeostasis constrains fetal hematopoietic stem cell pool expansion in Fanconi anemia
The Fanconi anemia pathway and ubiquitin
Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells
Fanconi anemia : clinical, cytogenetic and experimental aspects
Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Fanconi anemia
Current and emerging therapeutic strategies for Fanconi anemia
High content drug screening for Fanconi anemia therapeutics
Fanconi anemia pathway and its relationship with cancer
A minimal Fanconi Anemia complex in early diverging fungi
Tongue cancer following hematopoietic cell transplantation for Fanconi anemia
Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia
Therapeutic gene editing in CD 34 + hematopoietic progenitors from Fanconi anemia patients
Deregulated protein homeostasis constrains fetal hematopoietic stem cell pool expansion in Fanconi anemia
The Fanconi anemia pathway and ubiquitin
Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells
Fanconi anemia : clinical, cytogenetic and experimental aspects
Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Fanconi anemia
Current and emerging therapeutic strategies for Fanconi anemia
High content drug screening for Fanconi anemia therapeutics
Fanconi anemia pathway and its relationship with cancer
A minimal Fanconi Anemia complex in early diverging fungi
Tongue cancer following hematopoietic cell transplantation for Fanconi anemia
Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia
Therapeutic gene editing in CD 34 + hematopoietic progenitors from Fanconi anemia patients
Deregulated protein homeostasis constrains fetal hematopoietic stem cell pool expansion in Fanconi anemia
The Fanconi anemia pathway and ubiquitin
Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells
Fanconi anemia : clinical, cytogenetic and experimental aspects
Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Fanconi anemia
Current and emerging therapeutic strategies for Fanconi anemia
High content drug screening for Fanconi anemia therapeutics
Fanconi anemia pathway and its relationship with cancer